These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38529684)

  • 1. HIV outcomes during the COVID-19 pandemic in people of Black ethnicities living with HIV in England.
    Ottaway Z; Campbell L; Fox J; Burns F; Hamzah L; Kegg S; Rosenvinge M; Schoeman S; Price D; Jones R; Miller RF; Tariq S; Post FA
    HIV Med; 2024 Jul; 25(7):885-892. PubMed ID: 38529684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical epidemiology of COVID-19 in people of black ethnicity living with HIV in the UK.
    Ottaway Z; Campbell L; Cechin LR; Patel N; Fox J; Burns F; Hamzah L; Kegg S; Rosenvinge M; Schoeman S; Price D; Jones R; Clarke A; Maan I; Ustianowski A; Onyango D; Tariq S; Miller RF; Post FA;
    HIV Med; 2024 May; 25(5):614-621. PubMed ID: 38213094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early HIV viral suppression associated with subsequent 12-month treatment success among people living with HIV in South Africa.
    Violette LR; Thomas KK; Dorward J; Quame-Amaglo J; Garrett N; Drain PK
    HIV Med; 2024 Jun; 25(6):759-765. PubMed ID: 38488308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV treatment outcomes among people with initiation CD4 counts >500 cells/µL after implementation of Treat All in South African public clinics: a retrospective cohort study.
    Dorward J; Sookrajh Y; Gate K; Khubone T; Mtshaka N; Mlisana K; Ngobese H; Yende-Zuma N; Garrett N
    J Int AIDS Soc; 2020 Apr; 23(4):e25479. PubMed ID: 32319203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral treatment interruption among people living with HIV during COVID-19 outbreak in China: a nationwide cross-sectional study.
    Sun Y; Li H; Luo G; Meng X; Guo W; Fitzpatrick T; Ao Y; Feng A; Liang B; Zhan Y; Sande A; Xie F; Wang Y; Qian HZ; Cai Y; Zou H
    J Int AIDS Soc; 2020 Nov; 23(11):e25637. PubMed ID: 33247541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.
    Nomah DK; Reyes-Urueña J; Díaz Y; Moreno S; Aceiton J; Bruguera A; Vivanco-Hidalgo RM; Llibre JM; Domingo P; Falcó V; Imaz A; Cortés C; Force L; Letang E; Vilaró I; Casabona J; Miro JM;
    Lancet HIV; 2021 Nov; 8(11):e701-e710. PubMed ID: 34655549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Infection Is Associated with Uncontrolled HIV Viral Load in Non-Hospitalized HIV-Infected Patients from Gugulethu, South Africa.
    Lambarey H; Blumenthal MJ; Chetram A; Joyimbana W; Jennings L; Tincho MB; Burgers WA; Orrell C; Schäfer G
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study.
    Kiweewa F; Esber A; Musingye E; Reed D; Crowell TA; Cham F; Semwogerere M; Namagembe R; Nambuya A; Kafeero C; Tindikahwa A; Eller LA; Millard M; Gelderblom HC; Keshinro B; Adamu Y; Maswai J; Owuoth J; Sing'oei VC; Maganga L; Bahemana E; Khamadi S; Robb ML; Ake JA; Polyak CS; Kibuuka H
    PLoS One; 2019; 14(2):e0211344. PubMed ID: 30721233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV: Survey Results From the MACS-WIHS Combined Cohort Study.
    D'Souza G; Tong W; Gustafson D; Alcaide ML; Lahiri CD; Sharma A; French AL; Palella FJ; Kempf MC; Mimiaga MJ; Ramirez C; Kassaye S; Rinaldo CR; Brown TT; Tien PC; Adimora AA
    J Acquir Immune Defic Syndr; 2022 Jan; 89(1):1-8. PubMed ID: 34878431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapy.
    Zheng L; Bosch RJ; Chan ES; Read S; Kearney M; Margolis DM; Mellors JW; Eron JJ; Gandhi RT;
    Antivir Ther; 2013; 18(1):39-43. PubMed ID: 22914318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa.
    Kassanjee R; Davies MA; Ngwenya O; Osei-Yeboah R; Jacobs T; Morden E; Timmerman V; Britz S; Mendelson M; Taljaard J; Riou J; Boulle A; Tiffin N; Zinyakatira N
    J Int AIDS Soc; 2023 Jun; 26(6):e26104. PubMed ID: 37339333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID-19 pandemic.
    Ka'e AC; Fokam J; Togna Pabo WLR; Nanfack A; Ngoufack Jagni Semengue E; Bouba Y; Nka AD; Tetang S; Beloumou G; Takou D; Chenwi C; Tommo Tchouaket MC; Abba A; Djupsa S; Sosso SM; Pamen NB; Otshudiema JO; Boum Y; Colizzi V; Ndjolo A; Perno CF; Ceccherini-Silberstein F; Santoro MM
    HIV Med; 2023 Jun; 24(6):691-702. PubMed ID: 36717222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the COVID-19 pandemic on HIV treatment gap lengths and viremia among people living with HIV British Columbia, Canada, during the COVID-19 pandemic: Are we ready for the next pandemic?
    Munasinghe LL; Yin W; Nathani H; Toy J; Sereda P; Barrios R; Montaner JSG; Lima VD
    Soc Sci Med; 2024 Jun; 350():116920. PubMed ID: 38703468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy: A Swedish observational study.
    Brattgård H; Björkman P; Nowak P; Treutiger CJ; Gisslén M; Elvstam O
    PLoS One; 2022; 17(5):e0268540. PubMed ID: 35580115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians.
    Souza IE; Zhang W; Diaz RS; Chaloner K; Klinzman D; Stapleton JT
    HIV Med; 2006 Jan; 7(1):25-31. PubMed ID: 16313289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stakeholder efforts to mitigate antiretroviral therapy interruption among people living with HIV during the COVID-19 pandemic in China: a qualitative study.
    Sun Y; Zhan Y; Li H; Yuan T; Gao Y; Liang B; Feng A; Li P; Zheng W; Fitzpatrick T; Wu D; Zhai X; Zou H
    J Int AIDS Soc; 2021 Sep; 24(9):e25781. PubMed ID: 34473409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical treatment interruption in chronic HIV-1 infection: time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study).
    Castagna A; Muccini C; Galli L; Bigoloni A; Poli A; Spagnuolo V; Nozza S; Racca S; Galli A; Cinque P; Carini E; Lazzarin A
    J Antimicrob Chemother; 2019 Jul; 74(7):2039-2046. PubMed ID: 31225610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and outcomes of people living with HIV hospitalized with COVID-19: a nationwide experience.
    Ceballos ME; Ross P; Lasso M; Dominguez I; Puente M; Valenzuela P; Enberg M; Serri M; Muñoz R; Pinos Y; Silva M; Noguera M; Dominguez A; Zamora F;
    Int J STD AIDS; 2021 Apr; 32(5):435-443. PubMed ID: 33533294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of self-report of HIV viral load among people with HIV on antiretroviral treatment.
    Sewell J; Daskalopoulou M; Nakagawa F; Lampe FC; Edwards S; Perry N; Wilkins E; O'Connell R; Jones M; Collins S; Speakman A; Phillips AN; Rodger AJ;
    HIV Med; 2017 Aug; 18(7):463-473. PubMed ID: 28004523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnicity and discordance in plasma HIV-1 RNA viral load and CD4+ lymphocyte count in a cohort of HIV-1-infected individuals.
    Smith PR; Sarner L; Murphy M; James B; Thomas JM; Skinner CJ; Aitken C
    J Clin Virol; 2003 Jan; 26(1):101-7. PubMed ID: 12589840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.